Kyverna Therapeutics, Inc. KYTX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $32.19M-74.1% | $124.09M+263% | $34.16M-36.1% | $53.44M-6.0% | $56.87M-41.1% | ||
| $204.25M+31.6% | $155.16M+13.3% | $136.97M-13.4% | $158.24M-14.8% | $185.78M-1.9% | ||
| $241.73M-14.6% | $282.95M+61.8% | $174.93M-18.4% | $214.33M-13.5% | $247.65M-14.8% | ||
| $1.34M-13.1% | $1.55M-13.8% | $1.79M-17.1% | $2.16M-11.2% | $2.44M-27.2% | ||
| $257.02M-12.5% | $293.83M+57.0% | $187.16M-17.4% | $226.51M-13.1% | $260.66M-14.4% | ||
| $29.84M+11.7% | $26.71M+2.6% | $26.03M-21.0% | $32.95M+18.1% | $27.89M+3.8% | ||
| $221K-28.0% | $307K+61.6% | $190K-34.9% | $292K-42.4% | $507K-34.9% | ||
| $29.67M-18.7% | $36.49M+7.7% | $33.87M-14.9% | $39.79M+19.5% | $33.29M-1.4% | ||
| $61.44M-0.2% | $61.55M+74.8% | $35.21M-16.4% | $42.13M+15.0% | $36.65M-3.7% | ||
| —— | —— | —— | —— | —— | ||
| -$464.56M-9.4% | -$424.83M-9.8% | -$387.02M-10.5% | -$350.24M-13.7% | -$308.16M-16.9% | ||
| $195.58M-15.8% | $232.28M+52.9% | $151.95M-17.6% | $184.38M-17.7% | $224.01M-16.0% | ||
| $257.02M-12.5% | $293.83M+57.0% | $187.16M-17.4% | $226.51M-13.1% | $260.66M-14.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Kyverna Therapeutics, Inc.'s total assets?
- Kyverna Therapeutics, Inc. (KYTX) holds $257.0M in total assets, down 1.4% year over year.
- How much debt does Kyverna Therapeutics, Inc. have?
- Kyverna Therapeutics, Inc. carries $9.2M in total debt against $195.6M of shareholders' equity, a debt-to-equity ratio of 0.05.
- How much cash does Kyverna Therapeutics, Inc. have?
- Kyverna Therapeutics, Inc. holds $32.2M in cash and equivalents.
- Can Kyverna Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 8.15 — current assets exceed current liabilities.
- Where does Kyverna Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Kyverna Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.